GEVELOT SA (ALGEV.PA) Fundamental Analysis & Valuation

EPA:ALGEV • FR0000033888

Current stock price

175 EUR
+1 (+0.57%)
Last:

This ALGEV.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. ALGEV.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALGEV was profitable.
  • In the past year ALGEV had a positive cash flow from operations.
  • Each year in the past 5 years ALGEV has been profitable.
  • ALGEV had a positive operating cash flow in 4 of the past 5 years.
ALGEV.PA Yearly Net Income VS EBIT VS OCF VS FCFALGEV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

  • ALGEV has a worse Return On Assets (0.13%) than 69.81% of its industry peers.
  • ALGEV has a worse Return On Equity (0.16%) than 67.92% of its industry peers.
  • The Return On Invested Capital of ALGEV (0.48%) is worse than 77.36% of its industry peers.
  • ALGEV had an Average Return On Invested Capital over the past 3 years of 3.04%. This is significantly below the industry average of 8.73%.
Industry RankSector Rank
ROA 0.13%
ROE 0.16%
ROIC 0.48%
ROA(3y)2.68%
ROA(5y)2.17%
ROE(3y)3.82%
ROE(5y)3.1%
ROIC(3y)3.04%
ROIC(5y)2.57%
ALGEV.PA Yearly ROA, ROE, ROICALGEV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8

1.3 Margins

  • Looking at the Profit Margin, with a value of 0.23%, ALGEV is doing worse than 69.81% of the companies in the same industry.
  • In the last couple of years the Profit Margin of ALGEV has declined.
  • ALGEV has a worse Operating Margin (0.97%) than 78.30% of its industry peers.
  • In the last couple of years the Operating Margin of ALGEV has declined.
  • With an excellent Gross Margin value of 59.17%, ALGEV belongs to the best of the industry, outperforming 83.02% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ALGEV has remained more or less at the same level.
Industry RankSector Rank
OM 0.97%
PM (TTM) 0.23%
GM 59.17%
OM growth 3Y-37.75%
OM growth 5Y-26.99%
PM growth 3Y-30.66%
PM growth 5Y-22.17%
GM growth 3Y-1.14%
GM growth 5Y-0.99%
ALGEV.PA Yearly Profit, Operating, Gross MarginsALGEV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

8

2. ALGEV.PA Health Analysis

2.1 Basic Checks

  • ALGEV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • ALGEV has less shares outstanding than it did 1 year ago.
  • ALGEV has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, ALGEV has a worse debt to assets ratio.
ALGEV.PA Yearly Shares OutstandingALGEV.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K
ALGEV.PA Yearly Total Debt VS Total AssetsALGEV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • An Altman-Z score of 3.65 indicates that ALGEV is not in any danger for bankruptcy at the moment.
  • ALGEV has a Altman-Z score of 3.65. This is amongst the best in the industry. ALGEV outperforms 81.13% of its industry peers.
  • ALGEV has a debt to FCF ratio of 2.95. This is a good value and a sign of high solvency as ALGEV would need 2.95 years to pay back of all of its debts.
  • ALGEV's Debt to FCF ratio of 2.95 is fine compared to the rest of the industry. ALGEV outperforms 73.58% of its industry peers.
  • ALGEV has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
  • ALGEV has a Debt to Equity ratio of 0.04. This is amongst the best in the industry. ALGEV outperforms 89.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 2.95
Altman-Z 3.65
ROIC/WACC0.06
WACC7.81%
ALGEV.PA Yearly LT Debt VS Equity VS FCFALGEV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

  • ALGEV has a Current Ratio of 5.07. This indicates that ALGEV is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 5.07, ALGEV belongs to the best of the industry, outperforming 97.17% of the companies in the same industry.
  • ALGEV has a Quick Ratio of 3.68. This indicates that ALGEV is financially healthy and has no problem in meeting its short term obligations.
  • ALGEV's Quick ratio of 3.68 is amongst the best of the industry. ALGEV outperforms 95.28% of its industry peers.
Industry RankSector Rank
Current Ratio 5.07
Quick Ratio 3.68
ALGEV.PA Yearly Current Assets VS Current LiabilitesALGEV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1

3. ALGEV.PA Growth Analysis

3.1 Past

  • ALGEV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -96.89%.
  • The earnings per share for ALGEV have been decreasing by -17.19% on average. This is quite bad
  • The Revenue has been growing slightly by 2.81% in the past year.
  • Measured over the past years, ALGEV shows a small growth in Revenue. The Revenue has been growing by 5.90% on average per year.
EPS 1Y (TTM)-96.89%
EPS 3Y-22.49%
EPS 5Y-17.19%
EPS Q2Q%-60.37%
Revenue 1Y (TTM)2.81%
Revenue growth 3Y10.91%
Revenue growth 5Y5.9%
Sales Q2Q%14.91%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y3.55%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.03%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALGEV.PA Yearly Revenue VS EstimatesALGEV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
ALGEV.PA Yearly EPS VS EstimatesALGEV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2 4 6 8 10

2

4. ALGEV.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 388.89 indicates a quite expensive valuation of ALGEV.
  • Compared to the rest of the industry, the Price/Earnings ratio of ALGEV indicates a slightly more expensive valuation: ALGEV is more expensive than 71.70% of the companies listed in the same industry.
  • ALGEV is valuated expensively when we compare the Price/Earnings ratio to 26.86, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 12.93, ALGEV is valued correctly.
  • Based on the Price/Forward Earnings ratio, ALGEV is valued a bit cheaper than 67.92% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 37.39, ALGEV is valued rather cheaply.
Industry RankSector Rank
PE 388.89
Fwd PE 12.93
ALGEV.PA Price Earnings VS Forward Price EarningsALGEV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

  • 60.38% of the companies in the same industry are cheaper than ALGEV, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, ALGEV is valued a bit more expensive than the industry average as 60.38% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 40.36
EV/EBITDA 12.6
ALGEV.PA Per share dataALGEV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ALGEV does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)109.62
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

5

5. ALGEV.PA Dividend Analysis

5.1 Amount

  • ALGEV has a Yearly Dividend Yield of 2.87%.
  • Compared to an average industry Dividend Yield of 1.58, ALGEV pays a better dividend. On top of this ALGEV pays more dividend than 82.08% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, ALGEV pays a better dividend.
Industry RankSector Rank
Dividend Yield 2.87%

5.2 History

  • On average, the dividend of ALGEV grows each year by 21.15%, which is quite nice.
Dividend Growth(5Y)21.15%
Div Incr Years0
Div Non Decr Years5
ALGEV.PA Yearly Dividends per shareALGEV.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

  • ALGEV pays out 1132.65% of its income as dividend. This is not a sustainable payout ratio.
  • ALGEV's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP1132.65%
EPS Next 2YN/A
EPS Next 3YN/A
ALGEV.PA Yearly Income VS Free CF VS DividendALGEV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M
ALGEV.PA Dividend Payout.ALGEV.PA Dividend Payout, showing the Payout Ratio.ALGEV.PA Dividend Payout.PayoutRetained Earnings

ALGEV.PA Fundamentals: All Metrics, Ratios and Statistics

GEVELOT SA

EPA:ALGEV (4/10/2026, 7:00:00 PM)

175

+1 (+0.57%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)04-09
Earnings (Next)N/A
Inst Owners1.21%
Inst Owner ChangeN/A
Ins Owners7.72%
Ins Owner ChangeN/A
Market Cap131.25M
Revenue(TTM)148.53M
Net Income(TTM)340.00K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.87%
Yearly Dividend5.17
Dividend Growth(5Y)21.15%
DP1132.65%
Div Incr Years0
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 388.89
Fwd PE 12.93
P/S 0.88
P/FCF 40.36
P/OCF 16.65
P/B 0.62
P/tB 0.63
EV/EBITDA 12.6
EPS(TTM)0.45
EY0.26%
EPS(NY)13.53
Fwd EY7.73%
FCF(TTM)4.34
FCFY2.48%
OCF(TTM)10.51
OCFY6.01%
SpS198.04
BVpS281.9
TBVpS277.87
PEG (NY)109.62
PEG (5Y)N/A
Graham Number53.42
Profitability
Industry RankSector Rank
ROA 0.13%
ROE 0.16%
ROCE 0.64%
ROIC 0.48%
ROICexc 0.57%
ROICexgc 0.58%
OM 0.97%
PM (TTM) 0.23%
GM 59.17%
FCFM 2.19%
ROA(3y)2.68%
ROA(5y)2.17%
ROE(3y)3.82%
ROE(5y)3.1%
ROIC(3y)3.04%
ROIC(5y)2.57%
ROICexc(3y)3.55%
ROICexc(5y)3.63%
ROICexgc(3y)3.61%
ROICexgc(5y)3.72%
ROCE(3y)3.99%
ROCE(5y)3.37%
ROICexgc growth 3Y-45.56%
ROICexgc growth 5Y-35.96%
ROICexc growth 3Y-45.2%
ROICexc growth 5Y-34.4%
OM growth 3Y-37.75%
OM growth 5Y-26.99%
PM growth 3Y-30.66%
PM growth 5Y-22.17%
GM growth 3Y-1.14%
GM growth 5Y-0.99%
F-Score5
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 2.95
Debt/EBITDA 0.99
Cap/Depr 66.07%
Cap/Sales 3.12%
Interest Coverage 250
Cash Conversion 93.23%
Profit Quality 956.47%
Current Ratio 5.07
Quick Ratio 3.68
Altman-Z 3.65
F-Score5
WACC7.81%
ROIC/WACC0.06
Cap/Depr(3y)120.29%
Cap/Depr(5y)120.78%
Cap/Sales(3y)5.31%
Cap/Sales(5y)6.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-96.89%
EPS 3Y-22.49%
EPS 5Y-17.19%
EPS Q2Q%-60.37%
EPS Next Y3.55%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.81%
Revenue growth 3Y10.91%
Revenue growth 5Y5.9%
Sales Q2Q%14.91%
Revenue Next Year3.03%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-84.81%
EBIT growth 3Y-30.96%
EBIT growth 5Y-22.68%
EBIT Next Year84.55%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y140.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y261.56%
OCF growth 3Y-10.1%
OCF growth 5Y-0.33%

GEVELOT SA / ALGEV.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of GEVELOT SA (ALGEV.PA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALGEV.PA.


What is the valuation status for ALGEV stock?

ChartMill assigns a valuation rating of 2 / 10 to GEVELOT SA (ALGEV.PA). This can be considered as Overvalued.


Can you provide the profitability details for GEVELOT SA?

GEVELOT SA (ALGEV.PA) has a profitability rating of 3 / 10.


What is the financial health of GEVELOT SA (ALGEV.PA) stock?

The financial health rating of GEVELOT SA (ALGEV.PA) is 8 / 10.


Can you provide the dividend sustainability for ALGEV stock?

The dividend rating of GEVELOT SA (ALGEV.PA) is 5 / 10 and the dividend payout ratio is 1132.65%.